Parameter/model | Method | Pooled studies | Studies with patient matching | Studies without patient matching | Single-center studies | Multicenter studies | Studies published after 2015 | Studies published before 2015 |
---|---|---|---|---|---|---|---|---|
CD ≤ II (n = 16) FE | MA | 0.52 [0.43; 0.64] | 0.55 [0.42; 0.73] | 0.49 [0.37; 0.65] | 0.54 [0.43; 0.68] | 0.46 [0.31; 0.69] | 0.49 [0.39; 0.60] | 0.80 [0.46; 1.38] |
MR | There is a resulting formation and expansion of an advantage provided by the robotic over the open approach, which becomes statistically significant from 2015 and onwards | There is a resulting formation and expansion of an advantage provided by the robotic over the open approach, which becomes statistically significant from 2016 and onwards | There is an almost constant advantage provided by the robotic over the open approach, which becomes statistically significant from 2014 and onwards | There is a resulting formation and expansion of an advantage provided by the robotic over the open approach, which becomes statistically significant from 2017 and onwards | × | × | × |